Literature DB >> 5450141

The use of phenobarbitone to investigate the pathogenesis of unconjugated hyperbilirubinaemia.

M Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5450141      PMCID： PMC1702946     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  Phenobarbitone treatment in haemolytic jaundice.

Authors:  I Matsuda; A Takase
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

2.  Reduction in serum bilirubin by phenobarbital in adult unconjugated hyperhilirubinaemia. Is enzyme induction responsible?

Authors:  M J Whelton; L P Krustev; B H Billing
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

3.  Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome.

Authors:  M Black; B H Billing
Journal:  N Engl J Med       Date:  1969-06-05       Impact factor: 91.245

4.  An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium.

Authors:  L W Powell; B H Billing; H S Williams
Journal:  Australas Ann Med       Date:  1967-08

5.  Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital.

Authors:  S J Yaffe; G Levy; T Matsuzawa; T Baliah
Journal:  N Engl J Med       Date:  1966-12-29       Impact factor: 91.245
  5 in total
  1 in total

1.  Increased bilirubin conjugation in the liver and intestinal mucosa of phenobarbital treated rats.

Authors:  E A Rodriguez Garay; L S Morisori; M Del Rosario Spetale
Journal:  Experientia       Date:  1972-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.